CONCLUSION: The present study first demonstrates that FAM30A is a promising diagnostic biomarker, which is strongly linked to periodontitis staging (Stage I/II vs. Stage III/IV) and thus offers a new approach for clinical diagnosis. The gene discussed is FAM30A; the disease is periodontitis.